XTL Biopharmaceuticals Ltd. (FRA:H2K2)
0.5200
-0.0150 (-2.80%)
At close: Jan 9, 2026
-70.45% (1Y)
| Market Cap | 5.68M |
| Revenue (ttm) | 824.25K |
| Net Income (ttm) | -5.37M |
| Shares Out | n/a |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 730 |
| Open | 0.5450 |
| Previous Close | 0.5350 |
| Day's Range | 0.5200 - 0.5450 |
| 52-Week Range | 0.4440 - 4.0000 |
| Beta | n/a |
| RSI | 38.49 |
| Earnings Date | Mar 12, 2026 |